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Erratum
In the June 2000 issue, in the article “Localization of
Psoriasis-Susceptibility Locus PSORS1 to a 60-kb Interval
Telomeric to HLA-C,” by Nair et al. (66:1833–1844), the
authors have identified errors in five allele designations
in table 2. A revised version of the table is presented here
(table 2). These errors were made during preparation of
the table, not in the genotypes that were used for the
analysis. For risk cluster 17, the marker allele designations
for M6S169, M6S200, M6S165, and M6S201 should
have been 2, 4, 2, and 21, respectively (not 3, 2, 15, and
14). For cluster 19, the marker allele designation for
M6S201 should have been 9 (not 10). Of these, the only
errors that could yield a difference in the interpretation
of the results are those affecting M6S169 and M6S200,
because they produce a greater degree of similarity be-
tween cluster 17 and the remaining risk clusters. However,
these two errors did not influence the determination of
the boundaries of risk haplotypes 1 and 2, because that
determination was based on divergences between risk
clusters at M6S111 and M6S169, which persisted even
after the corrections were made. The authors are in the
process of sequencing the interval between risk haplotypes
1 and 2 in a collection of risk and nonrisk chromosomes.
This will allow them to determine with certainty whether
or not ancestral double-recombination events occurred
between risk haplotypes 1 and 2.
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Table 2
Haplotype Clusters (Expanded Sample) and Their Transmission to Affected Offspring
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Risk:
17 4 5 2 3 4 3 65 5 2 8 13 3 2 3 6 1 3 1 1 9 2 4 3 8 3 10 4 16 … 1 2 6 3 6 2 21 21:10 (67.7) .048
19 2 5 5 3 4 6 … 16 3 6 9 3 2 3 6 1 3 1 1 9 3 4 3 1 2 2 2 4 8 2 1 4 3 5 3 9 16:5 (76.2) .016
21 3 5 7 7 3 5 13 16 3 6 15 3 2 3 6 1 3 1 1 9 2 4 3 1 2 2 2 4 16 1 2 7 8 9 3 3 49:21 (70.0) .00082
22 3 5 7 7 3 5 13 16 3 6 15 3 2 3 6 1 3 1 1 9 2 4 3 1 2 2 2 4 16 1 2 4 5 12 … … 15:10 (60.0) .32
23 6 5 9 9 3 10 37 15 3 6 13 3 2 3 6 1 3 1 1 8 2 4 3 1 2 2 2 4 26 1 2 4 5 12 8 5 22:9 (71.0) .020
25 6 12 2 12 5 9 57 15 3 6 13 3 2 3 6 1 3 1 1 8 2 4 3 1 2 2 2 4 20 1 2 4 5 12 8 5 104:27 (79.4) 1.7 # 1011
Nonrisk:
14 6 5 11 6 3 5 7 9 3 7 1 6 … 5 1 3 3 1 1 4 4 6 3 2 2 2 2 4 23 2 2 5 2 5 3 5 57:87 (39.6) .012
26 8 3 2 16 3 12 8 7 3 7 15 3 5 3 6 1 3 1 1 10 2 4 3 6 2 1 2 4 1 1 2 7 2 6 3 16 53:64 (45.3) .31
30 5 5 5 12 5 13 35 19 2 4 10 3 1 3 6 5 2 2 2 2 4 4 3 6 14 8 4 1 19 1 1 6 2 6 1 10 10:16 (38.5) .24
44 3 4 4 16 3 13 60 12 2 3 15 3 7 6 6 5 2 2 4 2 1 6 3 8 2 3 2 4 11 2 1 6 2 8 4 9 5:15 (25.0) .025
48 6 9 2 10 2 1 62 14 2 3 15 3 8 6 6 5 2 2 4 2 1 6 3 8 2 2 2 4 11 2 1 6 2 6 4 11 12:21 (36.4) .12
54 4 14 10 6 1 10 55 9 2 3 13 3 9 7 6 7 2 2 4 2 1 6 3 8 2 2 2 4 11 2 1 8 2 6 2 … 11:11 (50.0) 1.00
56 4 4 7 7 4 5 44 3 2 16 15 3 9 6 6 5 2 2 4 2 1 5 3 6 2 1 2 3 20 2 1 6 3 3 3 5 19:22 (46.3) .64
58 4 4 7 7 4 5 44 11 2 4 8 7 1 3 6 5 2 1 1 4 4 6 4 6 6 8 4 16 18 1 2 5 2 6 3 15 8:11 (42.1) .49
63 5 9 6 3 3 15 44 4 2 5 10 3 13 7 3 3 1 1 1 2 4 5 4 8 13 13 4 1 … 1 2 4 2 6 1 12 16:27 (37.2) .093
66 5 9 10 17 5 3 38 14 3 12 2 3 12 7 2 3 1 2 6 9 5 5 3 8 20 8 4 16 8 1 2 6 2 6 8 … 15:15 (50.0) 1.00
61 2 6 4 3 2 3 65 6 2 8 8 7 13 1 1 1 3 1 1 5 2 5 4 4 14 6 4 17 13 1 2 6 5 12 … … 2:6 (25.0) …
NOTE.—All 34 markers subjected to long-haplotype clustering are displayed, in centromeric to telomeric order, from left to right. CDSN is located in RH2, between markers M6S190 and
M6S161. Ellipses (…) indicate that no allele occurred in 150% of the founder haplotypes comprising the cluster. Italicized numbers indicate that the allele shown occurred in 50–80% of the
founder haplotypes comprising the cluster. Nonitalicized numbers indicate that the allele shown occurred in 180% of the founder haplotypes comprising the cluster. Only the conserved alleles
of RH1 and RH2 are denoted by the left and right boxes, respectively. Alleles at HLA-B and HLA-C are indicated in boldface type.
a All risk clusters for which and the 10 most common nonrisk clusters are shown. Cluster 61 is shown for purposes of comparison with cluster 17 (see text for details). NoTNT 10
P value is given for cluster 61, because of an insufficient number of occurrences.
